Nils D Arvold

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET
    Nils D Arvold
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA, USA
    Technol Cancer Res Treat 15:234-42. 2016
  2. pmc Treatment options and outcomes for glioblastoma in the elderly patient
    Nils D Arvold
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA, USA
    Clin Interv Aging 9:357-67. 2014
  3. pmc Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ
    Nils D Arvold
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    Cancer 118:6022-30. 2012
  4. doi request reprint Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype
    Nils D Arvold
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Breast Cancer Res Treat 136:153-60. 2012
  5. doi request reprint Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma
    Nils D Arvold
    Harvard Radiation Oncology Program, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 75:1166-72. 2009
  6. ncbi request reprint Maternal HIV-1 DNA load and mother-to-child transmission
    Nils D Arvold
    Harvard Medical School, Boston, Massachusetts 02115, USA
    AIDS Patient Care STDS 21:638-43. 2007
  7. doi request reprint Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease
    Nils D Arvold
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    J Urol 186:91-6. 2011
  8. pmc A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma
    Ayal A Aizer
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts A A A, M C H, N D A, B M A Department of Pathology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts M A, K L L, A H L, S S Department of Neurosurgery, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts W L B, O A M, I F D Center for Neuro Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts E Q L, L N, M L R, A D N, D A R, P Y W, R B
    Neuro Oncol 18:269-74. 2016
  9. pmc Outcomes in stage I testicular seminoma: a population-based study of 9193 patients
    Clair J Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer 119:2771-7. 2013
  10. doi request reprint Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma
    Nils D Arvold
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 83:e495-500. 2012

Detail Information

Publications31

  1. pmc Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET
    Nils D Arvold
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA, USA
    Technol Cancer Res Treat 15:234-42. 2016
    ..Further study is warranted to determine its utility as an imaging biomarker of early response to EGFR-directed therapy. ..
  2. pmc Treatment options and outcomes for glioblastoma in the elderly patient
    Nils D Arvold
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA, USA
    Clin Interv Aging 9:357-67. 2014
    ....
  3. pmc Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ
    Nils D Arvold
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    Cancer 118:6022-30. 2012
    ..The authors described the characteristics of SBC and examined associations between the pathologic features of SBC and index DCIS cases...
  4. doi request reprint Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype
    Nils D Arvold
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Breast Cancer Res Treat 136:153-60. 2012
    ..Women with DM from these two BC subtypes have a high incidence of BM with a short latency, suggesting an ideal target population for trials evaluating the utility of MRI screening...
  5. doi request reprint Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma
    Nils D Arvold
    Harvard Radiation Oncology Program, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 75:1166-72. 2009
    ..Because surgical extirpation carries a high risk of postoperative blindness, vision-sparing treatment strategies are desirable...
  6. ncbi request reprint Maternal HIV-1 DNA load and mother-to-child transmission
    Nils D Arvold
    Harvard Medical School, Boston, Massachusetts 02115, USA
    AIDS Patient Care STDS 21:638-43. 2007
    ..02). In summary, HIV-1 DNA viral load was associated with MTCT in a population of women who received antiretroviral prophylaxis during pregnancy, independently from RNA viral load...
  7. doi request reprint Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease
    Nils D Arvold
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    J Urol 186:91-6. 2011
    ..We estimated the risk of prostate cancer specific mortality following radical prostatectomy or brachytherapy in men with low or intermediate risk prostate cancer using prospectively collected data...
  8. pmc A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma
    Ayal A Aizer
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts A A A, M C H, N D A, B M A Department of Pathology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts M A, K L L, A H L, S S Department of Neurosurgery, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts W L B, O A M, I F D Center for Neuro Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts E Q L, L N, M L R, A D N, D A R, P Y W, R B
    Neuro Oncol 18:269-74. 2016
    ..We sought to determine whether cytogenetic/genetic characterization may facilitate better estimation of the probability of recurrence...
  9. pmc Outcomes in stage I testicular seminoma: a population-based study of 9193 patients
    Clair J Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer 119:2771-7. 2013
    ..In particular, data describing long-term risks of cardiovascular disease (CVD) are conflicting...
  10. doi request reprint Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma
    Nils D Arvold
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 83:e495-500. 2012
    ....
  11. doi request reprint Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases
    Yufei Liu
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, 75 Francis Street, ASB1 L2, Boston, MA, 02115, USA
    J Neurooncol 124:429-37. 2015
    ..In summary, most patients with 1-4 brain metastases receiving SRS never require salvage WBRT or SRS, and the remainder do not require salvage treatment for a median of 6 months. ..
  12. doi request reprint Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients
    Nils D Arvold
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, Boston, Massachusetts
    Int J Radiat Oncol Biol Phys 92:384-9. 2015
    ..Hypofractionated radiation therapy (HRT) is frequently used but has not been compared to patients receiving standard fractionated radiation therapy (SRT) and temozolomide (TMZ)...
  13. doi request reprint Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy
    Andrea L Russo
    Harvard Radiation Oncology Program, Boston, MA 02215, USA
    Breast Cancer Res Treat 140:353-61. 2013
    ..Additional studies are needed to confirm this finding. ..
  14. doi request reprint Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer
    Nils D Arvold
    Harvard Radiation Oncology Program, Boston, Massachusetts, USA
    Cancer 118:3026-35. 2012
    ..Neoadjuvant chemotherapy before chemoradiation therapy (CRT) may improve outcomes for patients with locally advanced pancreatic cancer, but optimal management remains controversial, and prior reports have limited follow-up...
  15. doi request reprint Extent of resection and overall survival for patients with atypical and malignant meningioma
    Ayal A Aizer
    Department of Radiation Oncology, Brigham and Women s Hospital, Boston, Massachusetts
    Cancer 121:4376-81. 2015
    ..This study investigated the association between gross total resection (GTR) and all-cause mortality in patients with atypical and malignant meningioma...
  16. doi request reprint Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation
    Rifaquat Rahman
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA
    J Neurooncol 124:137-46. 2015
    ..47; 95 % CI, 1.01-2.13; P = .043), after adjustment for known prognostic factors. Hospitalization during the CRT phase is common among glioblastoma patients in the temozolomide era and is associated with shorter overall survival. ..
  17. pmc The role of whole brain radiation therapy in the management of melanoma brain metastases
    Michael A Dyer
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA, USA
    Radiat Oncol 9:143. 2014
    ....
  18. doi request reprint Evaluation of initial setup accuracy and intrafraction motion for spine stereotactic body radiation therapy using stereotactic body frames
    Zhaohui Han
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, Massachusetts Harvard Medical School, Boston, Massachusetts
    Pract Radiat Oncol 6:e17-24. 2016
    ....
  19. doi request reprint Local control after fractionated stereotactic radiation therapy for brain metastases
    Selvan Rajakesari
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, Boston, MA, USA
    J Neurooncol 120:339-46. 2014
    ..3 %). SRT appears to be a safe and reasonably effective technique to treat brain metastases deemed less suitable for SRS, though dose intensification strategies may further improve local control...
  20. doi request reprint Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases
    Michael A Dyer
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 83:e479-86. 2012
    ..In this retrospective study, we report on outcomes and prognostic factors for patients treated with stereotactic radiosurgery (SRS) for breast cancer brain metastases...
  21. doi request reprint Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy
    Nils D Arvold
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 83:e337-43. 2012
    ..The role of adjuvant radiotherapy (RT) in these patients has not been characterized...
  22. pmc Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy
    Nils D Arvold
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02215, USA
    J Clin Oncol 29:3885-91. 2011
    ..Prior results of breast-conserving therapy (BCT) have shown substantial rates of local recurrence (LR) in young patients with breast cancer (BC)...
  23. doi request reprint Steroid and anticonvulsant prophylaxis for stereotactic radiosurgery: Large variation in physician recommendations
    Nils D Arvold
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts Harvard Medical School, Boston, Massachusetts
    Pract Radiat Oncol 6:e89-96. 2016
    ..Because there are no clear guidelines regarding appropriate use, we sought to characterize prescribing practices and factors associated with these recommendations...
  24. pmc A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy
    Eudocia Q Lee
    Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts E Q L, D A R, A D N, L N, M L R, B M A, N D A, L D, J S, D L, S F R, J P, K H S, S C G, S H, P Y W Harvard Medical School, Boston, Massachusetts E Q L, E T W, D A R, A D N, L N, M L R, B M A, N D A, P Y W Massachusetts General Hospital, Boston, Massachusetts A M University of Pittsburgh, Pittsburgh, Pennsylvania J D University of California San Diego, La Jolla, California S K Beth Israel Deaconess Medical Center, Boston
    Neuro Oncol 18:849-54. 2016
    ..Fatigue is common among glioma patients undergoing radiotherapy (RT) and impacts quality of life (QOL). We evaluated whether armodafinil, a wakefulness-promoting medication, improves fatigue in glioma patients undergoing RT...
  25. doi request reprint Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin
    Lior Z Braunstein
    Harvard Radiation Oncology Program, Boston, MA, USA
    Breast Cancer Res Treat 149:555-64. 2015
    ..52). Modern approaches confer similarly favorable LR rates for ILC, IDC, and mixed histology breast cancers despite inherent histologic differences. Patients with ILC did not require more extensive surgical margins than those with IDC...
  26. doi request reprint Barriers to the implementation of surveillance for stage I testicular seminoma
    Nils D Arvold
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    Int J Radiat Oncol Biol Phys 84:383-9. 2012
    ..Because studies suggest that radiation oncologists in the United States continue to recommend RT for these patients, we sought to identify factors associated with management recommendations...
  27. pmc Updates in the management of brain metastases
    Nils D Arvold
    St Luke s Radiation Oncology Associates, St Luke s Cancer Center, Whiteside Institute for Clinical Research and University of Minnesota Duluth, Duluth, Minnesota N D A Center for Neuro Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts E Q L, P Y W Harvard Medical School, Boston, Massachusetts E Q L, B M A, N U L, I F D, P Y W Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland M P M Department of Medical Oncology, City of Hope, Duarte, California K M Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts B M A Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts N U L Department of Medicine, Division of Hematology Oncology, University of North Carolina, Chapel Hill, North Carolina C K A Department of Neurology Neuro Oncology, University of Turin, Turin, Italy R S Division of Medical Oncology, University of Colorado Denver, Denver, Colorado D R C Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio M A V Department of Neurosurgery
    Neuro Oncol 18:1043-65. 2016
    ....
  28. doi request reprint Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors
    Ayal A Aizer
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, 75 Francis Street, ASB1 L2, Boston, MA, 02115, USA
    J Neurooncol 124:291-7. 2015
    ..004). Patients receiving radiotherapy for tumors near but not distant from the central vasculature of the brain are at increased risk for death secondary to CVD, which should be considered when counseling patients. ..
  29. pmc Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma
    Ayal A Aizer
    Harvard Radiation Oncology Program, Brigham and Women s Hospital, Boston, Massachusetts A A A Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts N D A, B M A Department of Biostatistics, Dana Farber Cancer Institute, Boston, Massachusetts P C Department of Neurosurgery, Brigham and Women s Hospital, Boston, Massachusetts E B C, A J G, M D J, O A M, I F D Center for Neuro Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts P Y W, D A R, E Q L, L N, M L R, R B Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania S E W Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts S H R, S S, M A
    Neuro Oncol 16:1547-53. 2014
    ..The impact of adjuvant radiation in patients with atypical meningioma remains poorly defined. We sought to determine the impact of adjuvant radiation therapy in this population...
  30. pmc Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival
    Phillip J Gray
    Harvard Radiation Oncology Program, Boston, USA
    Lung Cancer 85:239-44. 2014
    ..We sought to analyze the effect of differing therapeutic paradigms in this subpopulation...
  31. pmc Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning
    Nils D Arvold
    Harvard Radiation Oncology Program, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 80:1383-90. 2011
    ..Dimensions of the primary tumor are increasingly relevant in an era of highly conformal radiotherapy...